Overview

Effect of Metformin on Frailty in 12 Subjects

Status:
Active, not recruiting

Trial end date:
2021-12-01

Target enrollment:

Participant gender:

Summary

This study will test whether chronic metformin administration will improve longevity of the cell, improves its machinery by reducing aging-related biochemical parameters and thereby improving physical performance, as measured by short physical performance battery test.

Phase:

Phase 2

Details

Lead Sponsor:

Mayo Clinic

Treatments:

Metformin